EPS Creative Health Technology Group Limited Issues Profit Warning for FY2026
Key Points from the Announcement
- Expected Loss: The Group is projected to record a loss ranging from HK\$9.5 million to HK\$11.5 million for the year ended 31 March 2026, compared to the profit of HK\$30.4 million recorded in the previous year.
- Factors Contributing to the Loss:
- Decrease in fair value gain on promissory notes due to non-controlling interests.
- Absence of gain on disposals of subsidiaries during the reporting year.
- Decline in revenue from the garment business segment, primarily due to the loss of the Group’s top customer in that segment.
- Notably, the reporting year did not see impairment loss on goodwill or research and development expenses, which partially offset the negative factors.
- Status of Results: The financial information is based on preliminary unaudited management accounts. Final audited results are expected to be published in late June 2026.
Implications for Shareholders and Investors
- The expected swing from a significant profit in the previous year to a loss this year is likely to be price-sensitive and may affect the share value.
- The loss of the top customer in the garment segment, as previously disclosed, represents a structural change in revenue generation and could impact future business prospects.
- Shareholders and potential investors are specifically advised to exercise caution when dealing in the shares of the Company.
- The announcement has not yet been verified by external auditors or the audit committee, meaning figures could be subject to change.
- Further details will be provided in the annual results announcement scheduled for late June 2026.
Board Composition
The Board includes six executive directors, one non-executive director, and four independent non-executive directors, reflecting a diverse leadership structure. The executive director, Miyano Tsumoru, issued the announcement.
Conclusion
The substantial turnaround from profit to loss, driven by multiple factors including the loss of a major customer and absence of non-recurring gains, is a material event for the Company. Investors should closely monitor upcoming disclosures and exercise caution in trading shares.
Disclaimer
This article is based on the Company’s preliminary unaudited accounts and statements. Investors should refer to the final audited results and official communications for definitive information. The content herein does not constitute investment advice.
EPS創意健康科技集團有限公司發出2026財年盈利警告
公告重點
- 預期虧損：集團預計截至2026年3月31日止年度將錄得約港幣950萬至1,150萬元的虧損，而上一年度則錄得約港幣3,040萬元的盈利。
- 虧損主因：
- 因非控股權益導致可供出售票據公允價值收益減少。
- 本年度未有處置附屬公司收益。
- 服裝業務收入下降，主要因失去該業務板塊的最大客戶。
- 值得留意的是，本年度並未有商譽減值損失及研發開支，部分抵銷負面因素。
- 業績狀況：財務資料基於初步未經審核管理帳目，最終經審核業績預計於2026年6月下旬公布。
對股東及投資者的影響
- 由盈利轉為虧損，屬價格敏感資料，可能對股價造成影響。
- 服裝業務最大客戶流失，屬結構性收入變化，或影響未來業務前景。
- 公告特別提醒股東及潛在投資者於買賣公司股份時需謹慎。
- 公告尚未經外部審核或審核委員會確認，數據或有調整。
- 更多詳情將於6月下旬公布的全年業績公告內披露。
董事會組成
董事會包括六位執行董事、一位非執行董事及四位獨立非執行董事，反映多元領導架構。本公告由執行董事宮野勉發出。
總結
由盈利轉為重大虧損，涉及多項因素，包括失去主要客戶及缺乏一次性收益，屬公司重大事件。投資者應密切留意後續公告，審慎操作股份。
免責聲明
本文章根據公司初步未經審核帳目及聲明撰寫。投資者應參考最終經審核業績及官方公告以獲取准確資訊。本文不構成投資建議。
